514 filings
Page 9 of 26
8-K
8ff9wfeh2ji1 6a
6 May 15
Arqule Reports First Quarter 2015 Financial Results
12:00am
8-K
w4pxyn
4 Mar 15
Results of Operations and Financial Condition
12:00am
8-K
wxv3mbx
12 Nov 14
Arqule Announces Collaboration with Nih for Clinical
12:00am
8-K
1r2u u31svdemaiucf
10 Nov 14
Arqule Announces Third Quarter Fiscal 2014 Results
12:00am
8-K
3vpfzumc
10 Nov 14
Arqule Announces Positive Top-line Results of Nih- Sponsored Phase 2 Trial of Tivantinib In Prostate Cancer
12:00am
S-8 POS
es4m1q34h4pgqwewr9
23 Sep 14
Registration of securities for employees (post-effective amendment)
12:00am
S-8
8em66 mnf99uw
23 Sep 14
Registration of securities for employees
12:00am
S-8
43vb475ofu4 sy5wzktp
23 Sep 14
Registration of securities for employees
12:00am
8-K
g4ds5h29vf34ty4mqcge
5 Aug 14
Arqule Reports Second Quarter 2014 Financial Results
12:00am
8-K
k4l tf2md5arr8
30 May 14
Arqule Announces Data Presentations with Tivantinib to Be Featured at Asco 2014
12:00am
8-K
iso0qo
16 May 14
Report of Matters Voted Upon by Stockholders
12:00am
8-K
3z491f
7 May 14
Arqule Reports First Quarter 2014 Financial Results
12:00am
8-K
69z7kfqq6dt40
5 Mar 14
Results of Operations and Financial Condition
12:00am